Search hospitals

>

Michigan

>

Grosse Pointe

Academic Hematology Oncology Specialists

Claim this profile

Grosse Pointe, Michigan 48236

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Breast cancer

Conducts research for Cancer

Conducts research for Non-Small Cell Lung Cancer

133 reported clinical trials

6 medical researchers

Photo of Academic Hematology Oncology Specialists in Grosse PointePhoto of Academic Hematology Oncology Specialists in Grosse PointePhoto of Academic Hematology Oncology Specialists in Grosse Pointe

Summary

Academic Hematology Oncology Specialists is a medical facility located in Grosse Pointe, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Academic Hematology Oncology Specialists is involved with conducting 133 clinical trials across 286 conditions. There are 6 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.

Area of expertise

1

Lung Cancer

Global Leader

Academic Hematology Oncology Specialists has run 27 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Breast Cancer

Global Leader

Academic Hematology Oncology Specialists has run 25 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Academic Hematology Oncology Specialists

Bladder Cancer

Lung Cancer

Breast Cancer

Esophageal cancer

Breast cancer

Multiple Myeloma

Bladder Carcinoma

Prostate Cancer

Gastric cancer

Non-Small Cell Lung Cancer

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Recruiting

1 award

Phase 2

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Academic Hematology Oncology Specialists?